Dror Bashan - Feb 25, 2022 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
President and CEO, Director
Signature
/s/ Dror Bashan
Stock symbol
PLX
Transactions as of
Feb 25, 2022
Transactions value $
$0
Form type
4
Date filed
2/28/2022, 04:01 PM
Next filing
Apr 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Award +638K +142.33% 1.09M Feb 25, 2022 By Trust F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020.
F2 To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.